Active substance
Cupric
- US FDA 8
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| CUPRIC CHLORIDE IN PLASTIC CONTAINER | EQ 0.4MG COPPER/ML | injectable · injection | HOSPIRA | Prescription | 26 Jun 1986 |
| CUPRIC CHLORIDE | EQ 0.4MG COPPER/ML | injectable · injection | EXELA PHARMA | Prescription | 31 Oct 2022 |
| CUPRIC SULFATE | EQ 0.4MG COPPER/ML | injectable · injection | AM REGENT | Prescription | 16 Dec 2022 |
| CUPRIC CHLORIDE | EQ 0.4MG COPPER/ML | injectable · injection | SOMERSET | Prescription | 30 Apr 2024 |
| CUPRIC CHLORIDE | EQ 0.4MG COPPER/ML | injectable · injection | STIRA | Prescription | 30 Apr 2024 |
| CUPRIC SULFATE | EQ 0.4MG COPPER/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | ABRAXIS PHARM | Discontinued | 5 May 1987 |
| CUPRIC SULFATE | EQ 0.4MG COPPER/ML | injectable · injection | APOTEX CORP | Discontinued | 19 Aug 2024 |
| CUPRIC CHLORIDE | EQ 0.4MG COPPER/ML | injectable · injection | AMNEAL | Discontinued | 26 Jan 2026 |
Safety signals and safety-related labeling changes
- US FDA 9 Jul 2025 CUPRIC CHLORIDE IN PLASTIC CONTAINER — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations - US FDA 30 Jun 2021 TRALEMENT — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Use in Specific Populations
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.